Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, May 26 2020

Full Issue

Plasma From Recovered Patients May Help Modestly With Recovery, But Results Are Far From Certain

The death rates in the small study were 12.8% among those who got the antibodies, compared with 24.4% among the patients who did not get this treatment, but analyses like this are fraught with difficulties when it's impossible to meet the gold-standard of clinical trials. In other scientific news: infection risk, obesity and what exactly R0 means.

The New York Times: Uncertain Results In Study Of Convalescent Serum For Covid-19

A small study of patients who were severely ill from the coronavirus hints that treatment with antibodies from recovered patients may modestly help recovery and survival, scientists reported on Friday. The study, although far from conclusive, is said to be the largest of subjects recovering from Covid-19, the illness caused by the coronavirus. Thirty-nine hospitalized patients were given intravenous infusions of antibodies from patients who had recovered from the condition. (Kolata, 5/22)

The New York Times: CDC Says Coronavirus Does Not Spread Easily On Surfaces 

Guidelines from the Centers for Disease Control and Prevention making the rounds this week on the internet are clarifying what we know about the transmission of the coronavirus. The virus does not spread easily via contaminated surfaces, according to the C.D.C. For those who were worried about wiping down grocery bags or disinfecting mailed packages, the news headlines highlighting this guidance in recent days might have brought some relief. But this information is not new: The C.D.C. has been using similar language for months. (Fortin, 5/22)

USA Today: Obesity Makes COVID-19 Risk Larger, Hospitals' Challenges Much Harder

The parents and two brothers of Silvia Deyanira Melendez, 24, are all in therapy after losing their daughter and sister to COVID-19 on March 28. "I don’t have the words to say how beautiful and nice to the family she was," her father, Marcos Melendez, said Friday. She weighed more than 300 pounds with a body mass index of 60, double the BMI considered obese. This most likely contributed heavily to her Type 2 diabetes, hypertension and a heart condition that required open heart surgery two years ago.  (O'Donnell, 5/23)

ABC News: What Is R0 For The COVID-19 Virus And Why It's A Key Metric For Re-Opening Plans 

If you've been reading coronavirus news coverage, you've likely stumbled across a reference to a term called "R0." ... Pronounced "R-naught," the reproductive number is an indicator of how contagious a disease is, or how easily it spreads from person to person in a community. The number is important because government leaders are using R0 as a proxy for determining whether their respective COVID-19 outbreaks are growing, shrinking and or holding steady. (Schumaker, 5/26)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF